Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -23.05% is 17% above its 2-year average of -27.77%, near the high end of its 2-year range (-36.26%–-23.05%).
23.18% above its 12-month average of -30.00%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -6.68%.
RETURN ON ASSETS (ROA)
-23.05%
RETURN ON ASSETS (ROA) AVG TTM
-30.00%
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.18%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-548.44%
vs the sector median at left
Shoulder Innovations, Inc.
Market Cap
$376.61M
Return on Assets (ROA)
-23.05%
TTM Avg
-30.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$463.35M
Return on Assets (ROA)
4.30%
TTM Avg
13.65%
3Y Avg
19.24%
5Y Avg
21.45%
Market Cap
$45.05M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$1.14B
Return on Assets (ROA)
-6.43%
TTM Avg
-17.46%
3Y Avg
-82.63%
5Y Avg
-55.94%
Market Cap
$1.91B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$2.99B
Return on Assets (ROA)
10.36%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$4.88B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
Market Cap
$5.10B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$5.59B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | -23.05% | -30.00% | N/A | N/A |
| NRC Health (NRC)vs › | $463.35M | 4.30% | 13.65% | 19.24% | 21.45% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | -382.32% | -98.02% | -80.35% | -65.77% |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | -6.43% | -17.46% | -82.63% | -55.94% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | -10.49% | -13.41% | -10.26% | -6.23% |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 10.36% | 11.11% | 1.40% | -7.68% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 15.41% | 17.55% | 14.67% | 15.71% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 5.08% | 4.88% | 4.58% | 3.44% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | -78.04% | -72.67% | -59.05% | -50.29% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -3.91% | 11.88% | 0.12% | -6.73% |
ROA
-23.1%
ROE
-28.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -23.75% |
| 2024-12-31 | -36.26% |
| 2023-12-31 | -23.31% |
